Stockscreener 앱 받기
0.27
1.82%
-0.005
시간 외 거래:
.27
전일 마감가:
$0.275
열려 있는:
$0.277
하루 거래량:
358.73K
Relative Volume:
0.03
시가총액:
$11.28M
수익:
$20.27M
순이익/손실:
$-63.80M
주가수익비율:
-0.1776
EPS:
-1.52
순현금흐름:
$-68.35M
1주 성능:
-13.32%
1개월 성능:
-32.84%
6개월 성능:
-41.61%
1년 성능:
-70.03%
1일 변동 폭
$0.2611
$0.2778
1주일 범위
$0.2604
$0.32
52주 변동 폭
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
명칭
Carisma Therapeutics Inc
전화
(267) 491-6422
주소
3675 MARKET STREET, PHILADELPHIA
CARM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.27 | 12.75M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-04-11 | 개시 | BTIG Research | Buy |
| 2023-10-03 | 개시 | CapitalOne | Overweight |
| 2023-07-06 | 개시 | Evercore ISI | Outperform |
| 2023-05-31 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-05-24 | 개시 | H.C. Wainwright | Buy |
| 2023-04-14 | 개시 | Robert W. Baird | Outperform |
모두보기
Carisma Therapeutics Inc 주식(CARM)의 최신 뉴스
CARISMA Therapeutics 2025 Q1 Earnings Loss Narrows by 51.2% - AInvest
Carisma Therapeutics Approves Reverse Stock Split - TipRanks
Carisma Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is it the right time to buy Carisma Therapeutics Inc. stockFree Market Volatility Navigation Tips - Jammu Links News
Is Carisma Therapeutics Inc. a good long term investmentCapitalize on market momentum for maximum gains - Jammu Links News
How many analysts rate Carisma Therapeutics Inc. as a “Buy”Capitalize on emerging investment opportunities - Jammu Links News
Why is Carisma Therapeutics Inc. stock attracting strong analyst attentionExplosive capital appreciation - Jammu Links News
How volatile is Carisma Therapeutics Inc. stock compared to the marketDynamic profit expansion - Jammu Links News
Published on: 2025-08-04 00:00:30 - Jammu Links News
Is Carisma Therapeutics Inc. stock overvalued or undervaluedIdentify winners with top-tier analysis - Jammu Links News
Does Carisma Therapeutics Inc. stock perform well during market downturnsOutstanding stock performance - Jammu Links News
What drives Carisma Therapeutics Inc. stock priceBuild a diversified portfolio for steady growth - Jammu Links News
Is Carisma Therapeutics Inc. a growth stock or a value stockExponentially increasing returns - Jammu Links News
Published on: 2025-08-02 00:52:36 - metal.it
How does Carisma Therapeutics Inc. compare to its industry peersFree Stock Target Finder That Work - Jammu Links News
What institutional investors are buying Carisma Therapeutics Inc. stockWealth Building Guidance For Smart Trading - jammulinksnews.com
What is the dividend policy of Carisma Therapeutics Inc. stockBest Dividend Tracker For Every Investor - Jammu Links News
Carisma Therapeutics Inc. stock daily chart insightsMomentum Based Equity Trading Plans Reviewed - metal.it
Carisma Therapeutics Inc. stock outlook for YEARMarket Momentum and Signal Alerts Suggest Reversal - metal.it
Will Carisma Therapeutics Inc. Benefit From Sector TailwindsBuy Low Sell High Stock Watch Strategy in Focus - metal.it
What makes Carisma Therapeutics Inc. stock price move sharplyValue Investing Picks With Stability Outlined - metal.it
Why Carisma Therapeutics Inc. stock attracts strong analyst attentionInvestment Strategy Designed for Capital Protection - metal.it
Moving Average Crossover Confirms Uptrend in Carisma Therapeutics Inc.Watchlist for Low Risk High Return Stocks Updated - metal.it
Published on: 2025-07-28 21:04:54 - metal.it
Applying big data sentiment scoring on Carisma Therapeutics Inc.AI Volatility Forecast and Risk Monitor - Newser
Carisma Therapeutics Inc. stock outlook for YEAR Short-Term Profit Alert With Entry Forecast - Newser
Carisma Therapeutics Inc. (NASDAQ:CARM) Receives $1.93 Average Target Price from Brokerages - Defense World
Top Risks to Consider Before Buying Carisma Therapeutics Inc. StockHigh Return Investment Tips - Newser
Has Carisma Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree Popular Stock Recommendations - Newser
Key External Factors That Drive Carisma Therapeutics Inc. Stock Price MovementsQuick Profit Idea Stream - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders - GlobeNewswire Inc.
How high can Carisma Therapeutics Inc. stock price go in 2025Triple-digit returns - Jammu Links News
Published on: 2025-07-25 09:50:28 - PrintWeekIndia
Carisma Therapeutics Inc. Stock Analysis and ForecastFree Popular Stock Recommendations - PrintWeekIndia
What analysts say about Carisma Therapeutics Inc. stockExtraordinary market timing - Jammu Links News
Carisma Therapeutics Inc (CARM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):